Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]
News [12654]
Articles [175]
Editorials [5]
Conferences [248]
elearning [17]
ASCO 2015: Latest developments in multiple myeloma
Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos
ASCO 2015: Latest developments in multiple myeloma ( Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos )
1 Jun 2015
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer...
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
1 Jun 2015
ASCO 2015: Latest in chronic lymphocytic leukaemia
Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos
ASCO 2015: Latest in chronic lymphocytic leukaemia ( Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos )
1 Jun 2015
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma
Dr James Larkin - Royal Marsden Hospital, London, UK
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma ( Dr James Larkin - Royal Marsden Hospital, London, UK )
1 Jun 2015
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia...
Dr William Slayton - University of Florida, Gainsville, USA
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL ( Dr William Slayton - University of Florida, Gainsville, USA )
1 Jun 2015
ASCO 2015: Latest developments in prostate cancer treatment
Prof Cora Sternberg, Prof Noel Clarke, Prof Eleni Efstathiou, Prof Karim Fizazi
ASCO 2015: Latest developments in prostate cancer treatment ( Prof Cora Sternberg, Prof Noel Clarke, Prof Eleni Efstathiou, Prof Karim Fizazi )
31 May 2015
Raloxifene retained approximately 81% of the effectiveness of tamoxifen in...
Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA
Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer ( Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA )
31 May 2015
Next generation inhibitors help overcome problems of resistance in ALK positive...
Dr Ross Camidge - University of Colorado, Denver, USA
Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer ( Dr Ross Camidge - University of Colorado, Denver, USA )
31 May 2015
Transarterial chemoembolization with or without sorafenib for intermediate...
Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an...
Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma ( Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an, China )
31 May 2015
Letrozole vs observation for HR positive breast cancer
Dr Nicholas Zdenkowski - University of Newcastle, Newcastle, Australia
Letrozole vs observation for HR positive breast cancer ( Dr Nicholas Zdenkowski - University of Newcastle, Newcastle, Australia )
31 May 2015
Risks of adjuvant whole brain radiation therapy outweigh benefits for patients...
Dr Jan Buckner - Mayo Clinic, Rochester, USA
Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases ( Dr Jan Buckner - Mayo Clinic, Rochester, USA )
31 May 2015
Preventive neck lymph node surgery improves early oral cancer survival
Dr Anil D’Cruz - Tata Memorial Centre, Mumbai, India
Preventive neck lymph node surgery improves early oral cancer survival ( Dr Anil D’Cruz - Tata Memorial Centre, Mumbai, India )
31 May 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation